1. Home
  2. NA vs AIDX Comparison

NA vs AIDX Comparison

Compare NA & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NA

Nano Labs Ltd

HOLD

Current Price

$2.90

Market Cap

68.2M

Sector

Technology

ML Signal

HOLD

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$1.79

Market Cap

58.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NA
AIDX
Founded
2019
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.2M
58.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NA
AIDX
Price
$2.90
$1.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.9K
232.9K
Earning Date
03-30-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.75
$1.51
52 Week High
$31.48
$14.09

Technical Indicators

Market Signals
Indicator
NA
AIDX
Relative Strength Index (RSI) 42.78 10.13
Support Level $2.86 $1.60
Resistance Level $3.42 $3.08
Average True Range (ATR) 0.19 0.31
MACD 0.00 0.19
Stochastic Oscillator 11.40 16.52

Price Performance

Historical Comparison
NA
AIDX

About NA Nano Labs Ltd

Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: